IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease.
<h4>Background</h4>Epidemiological studies indicate that a growing number of cirrhotic patients will develop hepatocellular carcinoma (HCC) in the next decade. Recent findings have demonstrated that Squamous cell carcinoma antigen 1 (SCCA1) and 2 (SCCA2) isoforms, now classified as serpi...
Main Authors: | Alessandra Biasiolo, Natascia Tono, Mariagrazia Ruvoletto, Santina Quarta, Cristian Turato, Gianmarco Villano, Luca Beneduce, Giorgio Fassina, Carlo Merkel, Angelo Gatta, Patrizia Pontisso |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22808225/?tool=EBI |
Similar Items
-
Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition
by: Alessandra Biasiolo, et al.
Published: (2023-04-01) -
SerpinB3 administration protects liver against ischemia-reperfusion injury
by: Cristian Turato, et al.
Published: (2022-10-01) -
SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease
by: Erica Novo, et al.
Published: (2022-07-01) -
Relationship Between SerpinB9 and Tumors and Research Progress of SerpinB9 in Skin Tumors
by: ZHANG Shan, et al.
Published: (2022-09-01) -
SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness
by: Santina Quarta, et al.
Published: (2023-05-01)